TY - JOUR
T1 - Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children
AU - Reddy, Nalla Anuraag
AU - Tom, Alex
AU - Lashkari, Harsha Prasada
N1 - Publisher Copyright:
© 2022
PY - 2022/6
Y1 - 2022/6
N2 - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.
AB - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.
UR - http://www.scopus.com/inward/record.url?scp=85157050432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85157050432&partnerID=8YFLogxK
U2 - 10.1016/j.phoj.2021.12.004
DO - 10.1016/j.phoj.2021.12.004
M3 - Article
AN - SCOPUS:85157050432
SN - 2468-1245
VL - 7
SP - 49
EP - 51
JO - Pediatric Hematology Oncology Journal
JF - Pediatric Hematology Oncology Journal
IS - 2
ER -
